Target intelligence / Profile preview

Pseudomonas aeruginosa iron-transport outer membrane receptor (TBDT)

Target
TBDT
Molecular classification
Transporter, Receptor, Outer membrane protein
01

Overview

Pseudomonas aeruginosa iron-transport outer membrane receptors are a family of TonB-dependent transporters (TBDTs) that play a vital role in the survival and pathogenesis of the bacterium by facilitating the uptake of essential iron (Luscher et al., 2018, PubMed: 29610408). These receptors, including FpvA for pyoverdine and FptA for pyochelin, recognize and bind iron-siderophore complexes in the extracellular environment and transport them across the outer membrane using energy derived from the TonB-ExbB-ExbD complex (Noinaj et al., 2010, PubMed: 20430111). Since iron is strictly sequestered by the host during infection, these receptors are indispensable for bacterial growth and the establishment of chronic infections, such as those seen in cystic fibrosis (Cornelis, 2010, PubMed: 20353451). In therapeutic applications, these receptors are targeted by siderophore-antibiotic conjugates, most notably Cefiderocol, which mimics natural siderophores to gain entry into the bacterial cell (Zhanel et al., 2019, PubMed: 30863996). This "Trojan Horse" approach allows the drug to bypass traditional resistance mechanisms like porin loss or efflux pump overexpression, making these receptors high-value targets for treating multi-drug resistant Pseudomonas infections (Wu et al., 2020, PubMed: 32152101).

Other names
TonB-dependent transporterSiderophore receptorFpvA (Ferripyoverdine receptor)FptA (Ferripyochelin receptor)HasR (Heme receptor)PfeA (Enterobactin receptor)PirA (Pyochelin-like receptor)
02

Mechanism of action

Siderophore-mediated active transport (Trojan Horse mechanism)

03

Biological functions

Iron acquisitionSiderophore transportHeme uptakeNutrient acquisitionOther
04

Disease associations

InfectionCystic fibrosisPneumoniaSepsis
05

Safety considerations

Resistance via receptor mutationDownregulation of receptor expressionCompetition with endogenous siderophoresReduced efficacy in iron-rich environments
06

Interacting drugs

Cefiderocol

2 more in the full profile.

07

Biomarkers

Pseudomonas aeruginosa infectionFpvA expressionFptA expression

Beyond the preview

Go deeper on Pseudomonas aeruginosa iron-transport outer membrane receptor (TBDT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pseudomonas aeruginosa iron-transport outer membrane receptor (TBDT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call